These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
614 related items for PubMed ID: 28401808
1. Associations between volume changes and spatial dose metrics for the urinary bladder during local versus pelvic irradiation for prostate cancer. Casares-Magaz O, Moiseenko V, Hopper A, Pettersson NJ, Thor M, Knopp R, Deasy JO, Muren LP, Einck J. Acta Oncol; 2017 Jun; 56(6):884-890. PubMed ID: 28401808 [Abstract] [Full Text] [Related]
5. Analyses of the factors influencing the accuracy of three-dimensional ultrasound in comparison with cone-beam CT in image-guided radiotherapy for prostate cancer with or without pelvic lymph node irradiation. Zhou S, Luo L, Li J, Lin M, Chen L, Shao J, Lu S, Ma Y, Zhang Y, Chen W, Liu M, Liu S, He L. Radiat Oncol; 2019 Jan 29; 14(1):22. PubMed ID: 30696488 [Abstract] [Full Text] [Related]
6. PTV margin analysis for prostate patients treated with initial pelvic nodal IMRT and prostate proton boost. Su Z, Li Z, Henderson R, Hoppe B, Nichols RC, Bryant C, Mendenhall W, Mendenhall N. Phys Med Biol; 2019 Feb 08; 64(4):04NT04. PubMed ID: 30630135 [Abstract] [Full Text] [Related]
7. Fractionated changes in prostate cancer radiotherapy using cone-beam computed tomography. Huang TC, Chou KT, Yang SN, Chang CK, Liang JA, Zhang G. Med Dosim; 2015 Feb 08; 40(3):222-5. PubMed ID: 25683282 [Abstract] [Full Text] [Related]
8. Relationship between pelvic organ-at-risk dose and clinical target volume in postprostatectomy patients receiving intensity-modulated radiotherapy. Stanic S, Mathai M, Cui J, Purdy JA, Valicenti RK. Int J Radiat Oncol Biol Phys; 2012 Apr 01; 82(5):1897-902. PubMed ID: 21536391 [Abstract] [Full Text] [Related]
9. Dosimetric and radiobiological consequences of computed tomography-guided adaptive strategies for intensity modulated radiation therapy of the prostate. Battista JJ, Johnson C, Turnbull D, Kempe J, Bzdusek K, Van Dyk J, Bauman G. Int J Radiat Oncol Biol Phys; 2013 Dec 01; 87(5):874-80. PubMed ID: 23978708 [Abstract] [Full Text] [Related]
10. Analysis of the Influence of Peripheral Anatomical Changes for CBCT-Guided Prostate Cancer Radiotherapy. Zhang Y, Zhang X, Li J, Zeng L, Wang X, Wu X, Li Y, Li X, Zhong R. Technol Cancer Res Treat; 2021 Dec 01; 20():15330338211016370. PubMed ID: 33982618 [Abstract] [Full Text] [Related]
11. Megavoltage cone beam computed tomography dose and the necessity of reoptimization for imaging dose-integrated intensity-modulated radiotherapy for prostate cancer. Akino Y, Koizumi M, Sumida I, Takahashi Y, Ogata T, Ota S, Isohashi F, Konishi K, Yoshioka Y. Int J Radiat Oncol Biol Phys; 2012 Apr 01; 82(5):1715-22. PubMed ID: 21620584 [Abstract] [Full Text] [Related]
12. Application of aSi-kVCBCT for Volume Assessment and Dose Estimation: An Offline Adaptive Study for Prostate Radiotherapy. Gandhi A, Vellaiyan S, Subramanian S, Swamy ST, Subramanian K, Ayyalusamy A. Asian Pac J Cancer Prev; 2019 Jan 25; 20(1):229-234. PubMed ID: 30678437 [Abstract] [Full Text] [Related]
13. Impact of daily soft-tissue image guidance to prostate on pelvic lymph node (PLN) irradiation for prostate patients receiving SBRT. Tyagi N, Hipp E, Cloutier M, Charas T, Fontenla S, Mechalakos J, Hunt M, Zelefsky M. J Appl Clin Med Phys; 2019 Jul 25; 20(7):121-127. PubMed ID: 31206236 [Abstract] [Full Text] [Related]
14. Dosimetric and volumetric effects in clinical target volume and organs at risk during postprostatectomy radiotherapy. Gawish A, Chughtai AA, Eble MJ. Strahlenther Onkol; 2019 May 25; 195(5):383-392. PubMed ID: 30334066 [Abstract] [Full Text] [Related]
15. A study on planning organ at risk volume for the rectum using cone beam computed tomography in the treatment of prostate cancer. Prabhakar R, Oates R, Jones D, Kron T, Cramb J, Foroudi F, Geso M, Gill S. Med Dosim; 2014 May 25; 39(1):38-43. PubMed ID: 24412028 [Abstract] [Full Text] [Related]
16. Dosimetric impact of organ at risk daily variation during prostate stereotactic ablative radiotherapy. Devlin L, Dodds D, Sadozye A, McLoone P, MacLeod N, Lamb C, Currie S, Thomson S, Duffton A. Br J Radiol; 2020 Apr 25; 93(1108):20190789. PubMed ID: 31971829 [Abstract] [Full Text] [Related]
17. A dosimetric comparison of tomotherapy and volumetric modulated arc therapy in the treatment of high-risk prostate cancer with pelvic nodal radiation therapy. Pasquier D, Cavillon F, Lacornerie T, Touzeau C, Tresch E, Lartigau E. Int J Radiat Oncol Biol Phys; 2013 Feb 01; 85(2):549-54. PubMed ID: 22677369 [Abstract] [Full Text] [Related]